You must log in to view this page.

Abrdn Life Sciences Investors – Ownership Summary

NYSE: HQL
Share price (7/2/26): $20.12
Market cap (7/2/26): $517 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Google Finance
SEC EDGAR

Insider Ownership

Mahai Chris LaVictoire »

12/34/56

Reilly Heather Carter »

12/34/56

≥5% Ownership

First Trust Portfolios LP »

SCHEDULE 13G/A

SCHEDULE 13G

SC 13G/A

SC 13G/A

SC 13G/A

Saba Capital Management, L.P. »

SCHEDULE 13D/A

SCHEDULE 13D/A

SCHEDULE 13D/A

SCHEDULE 13D/A

SCHEDULE 13D/A

Abrdn Life Sciences Investors – Ownership Summary Watch

Search in Documents

Key Exhibits

External Links

Insider Ownership

Mahai Chris LaVictoire »

Reilly Heather Carter »

≥5% Ownership

First Trust Portfolios LP »

Saba Capital Management, L.P. »

Abrdn Life Sciences Investors – Ownership Summary